UK | pharmaphorum

UK

News

MHRA gives Alnylam 'innovation passport' for hypertension dr...

The UK medicines regulator has awarded Alnylam's RNAi-based therapy zilebesiran for hypertension an 'innovation passport', a

News

UK grants early access to Argenx' efgartigimod for myastheni...

The UK regulatory authority has cleared the path for some patients with generalised myasthenia gravis (gMG) to get early access to Argenx' efgartigimod while it reviews the marketing applic

Patients

Representation in UK pharma: A progress report

Pharma understands that building equitable health services starts with building equitable institutions.

News

GSK said to be close to finding partner for science cluster ...

GlaxoSmithKline is reportedly close to finding a development partner for a major new investment project in the UK that will see a new bioscience cluster built near its research centre in St

News

group of chemical scientists working at the laboratory.

EU imposes Horizon funding block on UK scientists

UK scientists are being denied from joining the €95 billion Horizon research funding programme as a dispute over the trade border in Northern Ireland gets increasingly acrimonious.

News

Clear COVID health information essential for a return to healthcare as normal

Large UK study suggests vaccination helps treat long COVID

An observational study in the UK has found evidence that COVID-19 vaccination can help alleviate the lingering symptoms that afflict some people who contract the virus, often referred to as

MHRA gives Alnylam 'innovation passport' for hypertension dr...

UK grants early access to Argenx' efgartigimod for myastheni...

Representation in UK pharma: A progress report

GSK said to be close to finding partner for science cluster ...

EU imposes Horizon funding block on UK scientists

Large UK study suggests vaccination helps treat long COVID

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

UK

Editor's Picks